We are live on ! Find out more
AXN

Aoxing Pharmaceutical Company Inc.
AXN

Delisted

AXN was delisted on the 16th of October, 2017.

3 hedge funds and large institutions have $11K invested in Aoxing Pharmaceutical Company Inc. in 2014 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

25% less funds holding

Funds holding: 43 (-1)

84% less capital invested

Capital invested by funds: $67K → $11K (-$56K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
3
Holders Change
-1
Holders Change %
-25%
% of All Funds
0.08%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$4.38K
Name Holding Trade Value Shares
Change
Change in
Stake
Citadel Advisors
1
Citadel Advisors
Florida
$7K -$4.38K -16,267 -43%
EWM
2
Evercore Wealth Management
New York
$4K
UBS Group
3
UBS Group
Switzerland
+$6 +22 New

AXN Hedge Fund Activity: Q4 2014 in Review

3 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Aoxing Pharmaceutical Company Inc. (AXN) for Q4 2014, worth a combined $11K — down 84% from $67K a quarter earlier.

Fund positioning in AXN was balanced in Q4 2014: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 1 trimmed.

The largest seller was Citadel Advisors, cutting an estimated $4.38K.

  • 3 institutional investors held Aoxing Pharmaceutical Company Inc. (AXN) as of Q4 2014, down from 4 in Q3 2014.
  • Funds reported $11K of Aoxing Pharmaceutical Company Inc. stock for Q4 2014, down 84% quarter-over-quarter.
  • 1 fund opened new Aoxing Pharmaceutical Company Inc. positions in Q4 2014 and 1 closed out, a net change of 0 holders.
  • The largest Aoxing Pharmaceutical Company Inc. seller in Q4 2014 was Citadel Advisors, an estimated $4.38K sold.

Based on aggregated 13F filings for Q4 2014.